Pliant Therapeutics director Neil Exter retires; board size reduced to eight

PLIANT THERAPEUTICS, INC.

Neil Exter retired from the Board and Compensation Committee effective November 16, 2022.
Retirement not due to any disagreement with the company on operations, policies, or practices.
Board size reduced from nine to eight members, effective November 17, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Neil Exter

Member of the Board of Directors

PLRX · PLIANT THERAPEUTICS, INC.

Effective: 2022-11-16
Filed: November 18, 2022, 6:59 PM ET

On November 16, 2022, Neil Exter, MBA, a member of the Board of Directors (the “Board”) of Pliant Therapeutics, Inc. (the “Company”) since 2015, notified the Board that he would retire from the Board and as a member of the Compensation Committee of the Board, in each case effective as of November 16, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Neil Exter retired as Member of the Board of Directors at PLIANT THERAPEUTICS, INC..

Action: retired
Role: Member of the Board of Directors

Exact text from the filing

On November 16, 2022, Neil Exter, MBA, a member of the Board of Directors (the “Board”) of Pliant Therapeutics, Inc. (the “Company”) since 2015, notified the Board that he would retire from the Board and as a member of the Compensation Committee of the Board, in each case effective as of November 16, 2022.

View on SEC.gov

PLIANT THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-289077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.